Screener
Axsome Therapeutics AXSM Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Equipment, net | 567 | 562 |
| Right-of-use asset - operating lease | 20,014 | 20,858 |
| Goodwill | 12,042 | 12,042 |
| Intangible asset, net | 38,947 | 40,519 |
| Non-current inventory and other assets | 30,831 | 26,838 |
| Total assets | $713,607 | $689,805 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Axsome Therapeutics's intangibles (net)?
- Axsome Therapeutics (AXSM) reported intangibles (net) of $38.95M in Q1 2026.
- How has Axsome Therapeutics's intangibles (net) changed year-over-year?
- Axsome Therapeutics's intangibles (net) decreased by 14.1% year-over-year, from $45.32M to $38.95M.
- What is the long-term trend for Axsome Therapeutics's intangibles (net)?
- Over 3 years (2022 to 2025), Axsome Therapeutics's intangibles (net) has grown at a -12.1% compound annual growth rate (CAGR), from $59.66M to $40.52M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Axsome Therapeutics's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude